plc, of London, appointed Jonathan Lamb as general counsel and company secretary...and Robert Tenerowicz to vice president, process development and clinical supplies

Abgenix Inc., of Fremont, Calif., promoted Gisela Schwab to chief medical officer and Gregory Bell to vice president, clinical development, inflammation...Alteon Inc., of Ramsey, N.J., appointed Judith Hedstrom senior vice president, corporate development

Signature BioScience Inc., of Hayward, Calif., added Geoffrey Duyk to its board and Frances Heller as vice president, corporate development and legal affairs

Robert Johnson to senior vice president, medical affairs and corporate development...and Kevin Kaster to senior vice president, legal affairs

Advanced Neuromodulation Systems Inc., of Dallas, named Kenneth Hawari general counsel and executive vice president, corporate development

Neurogenetics Inc., of La Jolla, Calif., appointed Kumar Srinivasan director of corporate development...PanTherix Ltd., of Glasgow, UK, appointed Alan Clark nonexecutive chairman and Robin Cooper as a board member

Mojave Therapeutics, of Hawthorne, N.Y., named Jane Boswick vice president of corporate development, Christopher Fenimore director of finance, Joseph Mezzatesta director of quality and regulatory compliance and Michael Yamin director of intellectual property and licensing

Athersys Inc., of Cleveland, added William Lehmann as vice president of corporate development and Youssef Bennani as director of medicinal chemistry...CytoGenix Inc., of Houston, appointed Yin Chen vice president of research and development and added Charles Boyd and Nhan Nguyen to its board

Geron Corp., of Menlo Park, Calif., added Bruce Scott as vice president of corporate development and Elizabeth Aden as senior vice president and general manager for regenerative medicine...Novirio Pharmaceuticals Ltd., of Cambridge, Mass., appointed James Egan senior vice president, business and corporate development

Novirio Pharmaceuticals Ltd., of Cambridge, Mass., appointed James Egan senior vice president, business and corporate development...Zyomyx Inc., of Hayward, Calif., appointed Nicholas Naclerio senior vice president and chief business officer

Abingworth Management, of London, appointed John Berriman partner and John Shields assistant director...plc, of London, named Donald Joseph executive vice president, legal and commercial development for Amarin Pharmaceuticals Inc...Steve Guillen was named vice president, sales and marketing, for Amarin Pharmaceuticals Inc

and promoted Sergio Garcia-Rodriguez to vice president, legal, general counsel and assistant secretary...TheraMed Inc., of Rockville, Md., added Joseph Lehnen as chief financial officer and Eric Richman as vice president, corporate development

Crucell N.V., of Leiden, the Netherlands, appointed Arsia Amir-Aslani vice president, corporate development and strategy...DNA Sciences Inc., of Fremont, Calif., appointed Mark Perry and Kenneth Melmon to its board...Hollis-Eden Pharmaceuticals Inc., of San Diego, appointed Richard Trauger director, tumor and vaccine immunology

and said David Quysner will become nonexecutive chairman at the end of 2001...Anadys Pharmaceuticals Inc., of San Diego, appointed Michael Kamdar vice president of corporate development and strategy, Mary Yaroshevsky-Glanville director of human capital, Stephen Webber director of medicinal chemistry and Vlad Gregor associate director of high-throughput medicinal chemistry

and added Peter Cheung as senior scientist in pharmaceutical discovery...David Carlin to vice president and group leader, biostatistics and data management

Atairgin Technologies Inc., of Irvine, Calif., appointed Debra Liebert vice president of corporate development...Elitra Pharmaceuticals Inc., of San Diego, appointed Martin Rosenberg to its board and scientific advisory board and Philip Youngman vice president of discovery biology

Ontogen Corp., of Carlsbad, Calif., appointed Jeff Riley vice president, strategy and corporate development...and promoted Edward Hodgkin to vice president of global business development

Also, it added Catherine Kara as senior intellectual property counsel and both Brian Stalter and Douglas Haeuber as assistant general counsel...MetaPhore Pharmaceuticals Inc., of St. Louis, added John Vane, Joshua Boger and Adolphus Busch to its board

Dyax Corp., of Cambridge, Mass., named Jack Morgan senior vice president, corporate development and business operations...Pamela Hay senior vice president, corporate development and strategic opportunities